Aptevo Therapeutics Inc. (APVO): Price and Financial Metrics

Aptevo Therapeutics Inc. (APVO): $0.29

0.04 (+16.05%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add APVO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#271 of 341

in industry

APVO Price/Volume Stats

Current price $0.29 52-week high $10.80
Prev. close $0.25 52-week low $0.14
Day low $0.22 Volume 12,836,700
Day high $0.33 Avg. volume 3,806,430
50-day MA $0.22 Dividend yield N/A
200-day MA $1.55 Market Cap 5.37M

APVO Stock Price Chart Interactive Chart >


Aptevo Therapeutics Inc. (APVO) Company Bio


Aptevo Therapeutics, a biotechnology company, provides oncology and hematology therapeutics. Its marketed products include WinRho SDF for the treatment of autoimmune platelet disorders, as well as for the treatment of hemolytic disease of the newborn; and HepaGam B used for the prevention of hepatitis-B recurrence following liver transplantation in HBsAg-positive liver transplant patients, and for the treatment following exposure to hepatitis-B. The company was spun off from Emergent BioSolutions Inc. in 2016 and is based in Seattle, Washington.


APVO Latest News Stream


Event/Time News Detail
Loading, please wait...

APVO Latest Social Stream


Loading social stream, please wait...

View Full APVO Social Stream

APVO Price Returns

1-mo -17.99%
3-mo -28.06%
6-mo -59.21%
1-year -96.53%
3-year -99.90%
5-year -99.93%
YTD -96.36%
2023 -92.20%
2022 -70.52%
2021 -78.53%
2020 299.98%
2019 -48.46%

Continue Researching APVO

Here are a few links from around the web to help you further your research on Aptevo Therapeutics Inc's stock as an investment opportunity:

Aptevo Therapeutics Inc (APVO) Stock Price | Nasdaq
Aptevo Therapeutics Inc (APVO) Stock Quote, History and News - Yahoo Finance
Aptevo Therapeutics Inc (APVO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!